Allarity Therapeutics(ALLR)
BOSTON, MADiagnostics
Focus: Allarity Therapeutics is a Boston-based public oncology company focused on cancer treatments paired with companion diagnostics, particularly its proprietary Drug Response Predictor platform. The company operates at early clinical stages with a lean R&D footprint and modest cash reserves.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Allarity Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Allarity Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Allarity Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$0K
FY2025
Pipeline & Clinical Trials
Drug Response Predictor
Ovarian CancerClinical Trials (2)
NCT03643107Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
Phase 2Help build intelligence for Allarity Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.